Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 1
2006 4
2007 8
2008 4
2009 15
2010 31
2011 20
2012 21
2013 23
2014 26
2015 13
2016 10
2017 6
2018 6
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

159 results
Results by year
Filters applied: . Clear all
Page 1
Stabilization of exosome-targeting peptides via engineered glycosylation.
Hung ME, Leonard JN. Hung ME, et al. J Biol Chem. 2015 Mar 27;290(13):8166-72. doi: 10.1074/jbc.M114.621383. Epub 2015 Feb 5. J Biol Chem. 2015. PMID: 25657008 Free PMC article.
Therapeutic applications of extracellular vesicles: clinical promise and open questions.
György B, Hung ME, Breakefield XO, Leonard JN. György B, et al. Annu Rev Pharmacol Toxicol. 2015;55:439-464. doi: 10.1146/annurev-pharmtox-010814-124630. Epub 2014 Oct 3. Annu Rev Pharmacol Toxicol. 2015. PMID: 25292428 Free PMC article. Review.
LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer.
Zhang A, Zhao JC, Kim J, Fong KW, Yang YA, Chakravarti D, Mo YY, Yu J. Zhang A, et al. Cell Rep. 2015 Oct 6;13(1):209-221. doi: 10.1016/j.celrep.2015.08.069. Epub 2015 Sep 24. Cell Rep. 2015. PMID: 26411689 Free PMC article.
Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer.
Kregel S, Chen JL, Tom W, Krishnan V, Kach J, Brechka H, Fessenden TB, Isikbay M, Paner GP, Szmulewitz RZ, Vander Griend DJ. Kregel S, et al. Oncotarget. 2016 May 3;7(18):26259-74. doi: 10.18632/oncotarget.8456. Oncotarget. 2016. PMID: 27036029 Free PMC article.
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer.
Weichselbaum RR, Ishwaran H, Yoon T, Nuyten DS, Baker SW, Khodarev N, Su AW, Shaikh AY, Roach P, Kreike B, Roizman B, Bergh J, Pawitan Y, van de Vijver MJ, Minn AJ. Weichselbaum RR, et al. Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18490-5. doi: 10.1073/pnas.0809242105. Epub 2008 Nov 10. Proc Natl Acad Sci U S A. 2008. PMID: 19001271 Free PMC article.
Prostate-specific antigen screening: pro.
Loeb S, Catalona WJ. Loeb S, et al. Curr Opin Urol. 2010 May;20(3):185-8. doi: 10.1097/MOU.0b013e3283384047. Curr Opin Urol. 2010. PMID: 20224413 Free PMC article. Review.
TGF-β: duality of function between tumor prevention and carcinogenesis.
Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, Lee C, Grippo PJ. Principe DR, et al. J Natl Cancer Inst. 2014 Feb;106(2):djt369. doi: 10.1093/jnci/djt369. J Natl Cancer Inst. 2014. PMID: 24511106 Free PMC article. Review.
Precision therapeutic targeting of human cancer cell motility.
Xu L, Gordon R, Farmer R, Pattanayak A, Binkowski A, Huang X, Avram M, Krishna S, Voll E, Pavese J, Chavez J, Bruce J, Mazar A, Nibbs A, Anderson W, Li L, Jovanovic B, Pruell S, Valsecchi M, Francia G, Betori R, Scheidt K, Bergan R. Xu L, et al. Nat Commun. 2018 Jun 22;9(1):2454. doi: 10.1038/s41467-018-04465-5. Nat Commun. 2018. PMID: 29934502 Free PMC article.
Enrichment of Extracellular Vesicle Subpopulations Via Affinity Chromatography.
Hung ME, Lenzini SB, Stranford DM, Leonard JN. Hung ME, et al. Methods Mol Biol. 2018;1740:109-124. doi: 10.1007/978-1-4939-7652-2_9. Methods Mol Biol. 2018. PMID: 29388139
A genetic-based approach to personalized prostate cancer screening and treatment.
Helfand BT, Catalona WJ, Xu J. Helfand BT, et al. Curr Opin Urol. 2015 Jan;25(1):53-8. doi: 10.1097/MOU.0000000000000130. Curr Opin Urol. 2015. PMID: 25405931 Free PMC article. Review.
159 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page